FDA. Guidance For Industry. Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects.
I. INTRODUCTION
This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.
This guidance provides an overview of the responsibilities of a person who conducts a clinical investigation of a drug, biological product, or medical device (an investigator as defined in 21 CFR 312.3(b) and 21 CFR 812.3(i)). The goal of this guidance is to help investigators better meet their responsibilities with respect to protecting human subjects and ensuring the integrity of the data from clinical investigations. This guidance is intended to clarify for investigators and sponsors FDA’s expectations concerning the investigator’s responsibility (1) to supervise a clinical study in which some study tasks are delegated to employees or colleagues of the investigator or other third parties and (2) to protect the rights, safety, and welfare of study subjects.
FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.
Authors:
Center for Drug Evaluation and Research
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
OCTOBER 2009
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
10 – 11 April 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 18 April 2024InformaUnited States
-
17 – 19 April 2024SCDM (Society of Clinical Data Management)Poland
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Upcoming Clinical Trials
-
Odense University HospitalKarolinska Institutet; Umeå University; Sahlgrenska University Hospital, Sweden; Svendborg Hospital and other collaboratorsNot yet recruitingColorectal Cancer PreventionDenmark
-
Ahmet YuksekRecruitingEmergence Agitation | Anesthesia Recovery | Bispectral Index MonitorTurkey
-
Assiut UniversityNot yet recruitingArterio-venous Fistula
-
Anhui Medical UniversityRecruitingCognitive Impairment | Intracranial Atherosclerosis | Cerebrovascular EventChina
-
Methodist Health SystemRecruiting
-
Heart Rhythm Clinical and Research Solutions, LLCBoston Scientific CorporationNot yet recruiting
-
IRCCS Fondazione Stella MarisUniversità degli Studi di Trento; Ospedale Borgo Trento - VeronaRecruitingSensory and Behavioral Aspects With Particular Attention to Food Selectivity in Children With AutismAutism Spectrum DisorderItaly
-
Actym Therapeutics, Inc.Not yet recruiting
-
China-Japan Friendship HospitalRecruiting
-
University of KentuckyDepartment of Health and Human ServicesRecruitingDiabetes Mellitus, Type 2United States
-
AstraZenecaNot yet recruitingHeart Diseases | Cardiovascular Diseases | Heart Failure
-
Sohag UniversityRecruitingUpper Gastrointestinal Variceal Bleeding in Cirrhotic PatientsEgypt